Objectives: Describe IMCAS's new objective, namely the creation of a donation foundation. After 25 years of existence, we think it's time to give aesthetics and anti-ageing the status of science and evidence as a normal medical speciality.
Call for projects
Who can participate?
Board of Directors
Direction
Plan for the future

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Comexposium healthcare

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Comexposium healthcare

Objectives: the aim of the presentation is to demonstrate the impact of solar radiation on the facial ageing process and to establish photoprotection strategies to prevent photoageing

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: PDT stands out as one of the most effective therapeutic protocols licensed for treating actinic keratoses and field cancerization. Beyond its oncological impact, both the epidermal and dermal effects of PDT contribute to the dermal remodeling of photodamaged skin, resulting in significant photorejuvenation.

Introduction: "Photoaging, stemming from continuous exposure to ultraviolet (UV) irradiation, leads to the accumulation of DNA damage. Clinically, this manifests as thickened, rough skin with fine lines, coarse wrinkles, mottled pigmentation, elastosis, and precancerous lesions (actinic keratoses). This is the most common skin condition experienced by our patients

Materials / method: While conventional PDT requires a photosensitizer and a specific light source, Daylight PDT is a simple yet effective technique that should be widely embraced by dermatologists. Its primary focus is on treating pre-cancerous lesions, with the added benefit of enhancing skin quality.

Results: This talk explores various pre-treatment strategies, emphasizing the importance of drug penetration into the stratum corneum. Daylight PDT can be further improved with assisted medication administration, including pre-photosensitizer chemical or mechanical peeling or microneedling (0.25 to 0.50 mm) after photosensitizer, optimizing the results of subsequent aesthetic treatments. And if the patient needs to treat vascular and pigmentary problems, IPL can also be used as a light source, further improving the aesthetic result.

Conclusion: We propose initiating the anti-aging treatment protocol with PDT, not only to enhance aesthetic outcomes but also to ensure the prevention and treatment of pre-cancerous lesions. This approach emphasizes the medical aspect in aesthetic treatment.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: To describe new treatments of Vitiligo, focusing on sistemic treatments with Jak Inhibitors due to recent publications of new oral medicines to treat this condition.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability